Group photo;
Credit: Joanna Henckes
On Monday 6 July 2026, the Luxembourg Stock Exchange (LuxSE) announced that the International Finance Facility for Immunisation (IFFIm) had celebrated the 20th anniversary of its first vaccine bond issuance and listing on the Exchange during a dedicated Ring the Bell ceremony.
Held on Friday 3 July 2026 at LuxSE, the event marked two decades since IFFIm launched its inaugural vaccine bond in 2006. Since then, the United Kingdom (UK)-based organisation has mobilised more than €9.4 billion through 45 bond issuances in eight currencies, providing funding for immunisation programmes in lower-income countries through Gavi, the Vaccine Alliance. Throughout this period, LuxSE has served as the reference listing venue for IFFIm's debt instruments.
Founded in 2006, IFFIm helps accelerate funding for immunisation and global health programmes by transforming long-term donor commitments into immediately available financing through vaccine bond issuances. Working in partnership with Gavi, the Vaccine Alliance, the World Bank and eleven donor countries, the organisation has supported more than fourteen vaccine introductions and enabled Gavi to immunise more than 233 million additional children.
IFFIm currently receives long-term donor commitments from the UK, France, Italy, Spain, Sweden, Norway, South Africa, the Netherlands, Australia, Brazil and Canada.
The anniversary, held under the theme "Saving lives through vaccine bonds since 2006", reflected on two decades of innovation in development finance and global health while also looking ahead to future challenges and opportunities for immunisation programmes.
“For two decades, IFFIm’s vaccine bonds have stood as a powerful example of how capital markets can be mobilised to advance global health and social impact. Their success illustrates the vital role international investors play in financing essential public health initiatives through innovative and sustainable solutions. The Luxembourg Stock Exchange is proud to have supported IFFIm’s journey since its very first vaccine bond issuance in 2006 and we remain committed to fostering the development of impact-driven financing instruments that contribute to a healthier, more sustainable world,” said Julie Becker, CEO of LuxSE.
“We are honoured to hold our first anniversary public event at the Luxembourg Stock Exchange, which has been such an integral partner to IFFIm’s success over the past two decades. From our very first vaccine bond issuance, LuxSE has provided a trusted and global platform that connects our mission with committed investors. As we celebrate 20 years, we look ahead with renewed ambition to deepen this collaboration and continue harnessing capital markets to deliver life-saving vaccines for millions of children around the world,” added Georgina Baker, Chair of IFFIm.
The ceremony also featured speeches by Joanne Olivier, UK Ambassador to Luxembourg, Marthe Sylvie Essengue Elouma, Acting Director of Core Countries Segment at Gavi, the Vaccine Alliance, and Veronique Jacobs, Special Representative to the EU, Belgium, Luxembourg and NATO at The World Bank.
According to LuxSE, the anniversary highlighted the long-standing collaboration between the Exchange and IFFIm and reaffirmed the shared commitment of issuers, investors, donor countries and development partners to mobilising innovative financing solutions to improve health outcomes worldwide.
